Allogeneic UCB Therapy With EPO in Children With CP

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2013 by Bundang CHA Hospital
Sponsor:
Collaborators:
Ministry of Health & Welfare, Korea
LG Life Sciences
Chong Kun Dang Pharmaceutical
CHA University
Information provided by (Responsible Party):
MinYoung Kim, M.D., Bundang CHA Hospital
ClinicalTrials.gov Identifier:
NCT01991145
First received: November 17, 2013
Last updated: NA
Last verified: November 2013
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)